Cooperative Agreements to Support State-Based Safe Motherhood and Infant Health Initiative Programs

 

To promote optimal and equitable health in women and infants through public health surveillance, research, leadership, and partnership to move science to practice. In carrying out this mission, the Division of Reproductive Health: 1) Enhances the ability of others to identify and address male and female reproductive issues and infant health issues by providing technical assistance, consultation, and training worldwide; 2) supports national and state-based surveillance systems to monitor trends and investigate health issues; 3) conducts epidemiologic, behavioral, demographic and health services research; and 4) works with partners to translate research findings into health care practice, public health policy, and health promotion strategies.

General information about this opportunity
Last Known Status
Active
Program Number
93.946
Federal Agency/Office
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Type(s) of Assistance Offered
Cooperative Agreements
Program Accomplishments
Not Applicable.
Authorization
Public Health Service Act; Safe Motherhood, Section 317K; Prenatal and Postnatal Health, Section 317L, 42 U.S.C 247b-12 and 13.
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Official State and Territorial public health agencies. City of New York public health agency and District of Columbia. Applications may be submitted by public and private nonprofit and for-profit organizations and by governments and their agencies; that is, universities, colleges, research institutions, hospitals, other public and private nonprofit and for-profit organizations, State and local governments or their bona fide agents, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau, federally recognized Indian tribal governments, Indian tribes, or Indian tribal organizations, and small, minority, women-owned businesses.
Beneficiary Eligibility
Official State and Territorial public health agencies. City of New York public health agency and District of Columbia. Applications may be submitted by public and private nonprofit and for-profit organizations and by governments and their agencies; that is, universities, colleges, research institutions, hospitals, other public and private nonprofit and for-profit organizations, State and local governments or their bona fide agents, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau, federally recognized Indian tribal governments, Indian tribes, or Indian tribal organizations, and small, minority, women-owned businesses.
Credentials/Documentation
Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe evaluation procedures, and provide a budget with justification for funds requested. 2 CFR 200, Subpart E - Cost Principles applies to this program.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is required. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.
Application Procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Information on the submission of applications may be obtained from the Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention, 2920 Brandywine Rd, Atlanta, GA 30341. This program is subject to the provisions of 45 CFR 92. The standard application forms, as furnished by CDC and required by 45 CFR 92 for State and local governments, must be used for this program.
Award Procedure
After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public.
Deadlines
Contact the headquarters or regional office, as appropriate, for application deadlines.
Approval/Disapproval Decision Time
From 90 to 120 days.
Appeals
Not Applicable.
Renewals
Information on renewals may be obtained from the Grants Management Officer, Procurement and Grants Office, Centers for Disease Control and Prevention, 2920 Brandywine Road, Room 3000, Atlanta, GA 30341. This program is subject to the provisions of 45 CFR 92. The standard application forms, as furnished by CDC and required by 45 CFR 92 for State and local governments, must be used for this program.
How are proposals selected?
All programs: (1) The extent to which the application describes and presents appropriate data indicating an understanding of the problem, the program for which assistance is requested, and the purpose of the cooperative agreement; (2) the degree to which the workplan addresses the stated needs, is likely to achieve the purposes of the cooperative agreement, and describes the specific roles and responsibilities of participating personnel; (3) the degree to which the application provides a complete and achievable timetable of appropriate events; (4) the adequacy of the plan to monitor progress toward the stated objectives; (5) the extent to which the budget is reasonable, consistent with the problems identified and the scope of the program proposed to address these problems, and the intended use of cooperative agreement funds, and clearly reflects the applicant's intent to commit nonfederal resources to support the operational costs of these programs. PRAMS only: The degree to which the application describes the process for registering births in the State.
How may assistance be used?
PRAMS:
The Pregnancy Risk Assessment Monitoring System, is a surveillance project of the Centers for Disease Control and Prevention (CDC) and state health departments. PRAMS collects state-specific, population-based data on maternal attitudes and experiences before, during, and shortly after pregnancy.

PRAMS provides data for state health officials to use to improve the health of mothers and infants; allows CDC and the states to monitor changes in maternal and child health indicators (e.g., unintended pregnancy, prenatal care, breastfeeding, smoking, drinking, infant health); and enhances information from birth certificates used to plan and review state maternal and infant health programs. The PRAMS sample is chosen from all women who had a live birth recently, so findings can be applied to the state's entire population of women who have recently delivered a live-born infant. PRAMS not only provides state-specific data but also allows comparisons among participating states because the same data collection methods are used in all states.

SID/SUID (Sudden infant Death/Sudden Unexplained Infant Death):
The SUID Case Registry aims to generate public health surveillance information about SUID at the national, state, and local levels that is more detailed than what is currently available. Instead of creating an entirely new system, the SUID Case Registry enhances the National Center for Child Death Review program and their Case Reporting System.

The SUID Case Registry generates public health surveillance information that can comprehensively describe the circumstances and events surrounding SUID cases. This will allow researchers, medicolegal investigators, and program prevention planners to better understand characteristics associated with SUID, evaluate case investigation practices, and ultimately prevent infant deaths.

Validation of Prenatal Substance Use Screening Tools:
The purpose of this research is to validate and compare the performance of the most promising substance abuse screening tools that are already available in the literature (for example, the 4Ps-plus, the 5Ps, the Substance Use Risk Profile – Pregnancy Scale (SURP-P), the CRAFFT, the NIDA Quick Screen) and can be used among pregnant women seeking medical services (e.g. antenatal or delivery care) in clinical settings in the United States.

Medicaid Expansion and Reproductive Health Care for Women: The intent of this FOA is to study the use of medical services and health outcomes among low-income women of reproductive age (15-44 years), before and after expansion of Medicaid eligibility. This research will require linkage of state Medicaid data with other key maternal and child health datasets including, but not limited to, birth certificates, death certificates, and hospital discharge data.

Perinatal Quality Collaboratives:
This FOA will support states to enhance the capabilities of state-based perinatal quality collaboratives to improve the quality of perinatal care in their states, including but not limited to: reducing early elective deliveries, increasing use and documentation of use of antenatal steroids, increasing breastfeeding rates, and reducing central line-associated blood stream infections in neonates. Module B will continue to support the work of the 3 states that have successfully expanded their Perinatal Quality Collaborative through an existing FOA, CDC-RFA- DP11-1110, that ends September 29, 2014, and will support expansion of PQC projects and formal mentoring and capacity building for Module A awardees.

Maternal and Child Health Capacity Building:
The program promotes and improves the health and well-being of women, children, and families by building capacity at state, local, and tribal levels and to use and apply sound epidemiologic research and scientific information to maternal and child health programs and policies through collaborations with partners.

Special Interest Project (SIP)/Progestin contraception and HIV risk: Clinical and laboratory follow-up of a cohort of HIV-infected and uninfected women: The purpose of this SIP is to establish a cohort of HIV-infected and HIV-uninfected women on different types of progestin-containing contraception to assess differences in women’s continuation with a given method and the effects of long-term progestin use on markers of HIV risk and efficacy of ART. Also the project will support laboratory studies to analyze the effects of progestin on HIV shedding, inflammatory/immune markers in the genital tract, and the interaction of progestin with antiretroviral therapy on contraceptive and ART efficacy. Objectives in the topic area of Family Planning and HIV Prevention intend to Increase the proportion of pregnancies that are intended; increase the proportion of sexually experienced persons who received reproductive health services; reduce pregnancy rates among adolescent females; and reduce the rate of HIV transmission among adolescents and adults.

Teen Pregnancy Prevention:
The program is supporting public and private entities to fund medically accurate and age appropriate evidence-based or innovative program models to reduce teen pregnancy. The purpose of the program is to reduce teen pregnancy by working directly with publicly funded clinics to increase access to and use of reproductive health services among vulnerable youth. Activities include building the capacity of staff and clinical providers, establishing partnerships with youth-serving systems, and developing communication efforts. The primary target population is 15- to 19-year-olds, the age group among whom the majority of teen births occur; however, since the Society of Adolescent Health and Medicine and the United Nations Family Planning Association define adolescents as 15-24, the target age group may be expanded.

Development and Testing of a Clinic-Based Intervention to Increase Dual Protection against Unintended Pregnancy and STDs among High Risk Female Teens: The purpose of this funding opportunity is to develop and evaluate a clinic-based intervention addressing access to, motivation for, and adherence to dual protection strategies that concurrently protect against unintended pregnancies and sexually transmitted diseases (STDs), including human immunodeficiency virus (HIV) among high risk 15-19 year old females.
What are the requirements after being awarded this opportunity?
Reporting
Progress reports are required annually. Cash reports are not applicable. Progress reports are required annually. Annual financial reports are required at the end of each budget period. A final financial status report is due 90 days after the project period ends. Progress reports are required annually.
Auditing
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Records
Financial records, supporting documents, statistical records, and all other records pertinent to the cooperative agreements program shall be retained for a minimum of three years, or until completion and resolution of any audit in process or pending resolution. In all cases, records must be retained in accordance with PHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance
Project Period: up to five years. Budget Period: All programs: For 12 months. Method of awarding/releasing assistance: lump sum.
Who do I contact about this opportunity?
Regional or Local Office
None.
Headquarters Office
Deborah Wetterhall 4770 Buford Highway, Atlanta, Georgia 30341 Email: dwetterhall@cdc.gov Phone: (770) 488-6255
Website Address
http://www.cdc.gov
Financial Information
Account Identification
75-0948-0-1-550.
Obligations
(Cooperative Agreements) FY 14 $11,788,753; FY 15 est $13,401,055; and FY 16 est $13,401,055
Range and Average of Financial Assistance
No Data Available.
Regulations, Guidelines and Literature
PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000, (Rev.) April 1, 1994, applies to cooperative agreements.
Examples of Funded Projects
Not Applicable.

 



Federal Grants Resources